Innoviva, Inc. (INVA) Investor Relations Documents

Innoviva, Inc. (INVA) investor relations documents from the company's IR site: 1 presentation, 26 press releases; latest deck 2026-08-05. Read in-app with summaries. First-party data.

Corporate Presentation: Innoviva is a diversified biopharmaceutical company generating over $450M in LTM revenue through respiratory royalties and a high-growth specialty therapeutics platform.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-11Press releasePDF Version
2026-08-11Press releaseInnoviva Specialty Therapeutics’ Antimicrobial Therapies, XACDURO®, ZEVTERA® and NUZOLVENCE® Designated Finalists for th
2026-08-05PresentationCorporate Presentation
2026-08-05Press releasePDF Version
2026-08-05Press releaseInnoviva Reports Second Quarter 2026 Financial Results; Highlights Recent Company Progress
2026-06-25Press releasePDF Version
2026-06-25Press releasePDF Version
2026-06-25Press releasePDF Version
2026-06-23Press releasePDF Version
2026-06-23Press releasePDF Version
2026-06-22Press releasePDF Version
2026-06-22Press releasePDF Version
2026-06-18Press releasePDF Version
2026-06-18Press releaseNortiva Bio Launches to Develop Long-Acting Oral Medicines
2026-06-16Press releasePDF Version
2026-06-16Press releaseInnoviva Specialty Therapeutics Announces Distribution and Licensing Agreement with Dr. Reddy’s for XACDURO® in Select I
2026-06-01Press releasePDF Version
2026-06-01Press releaseInnoviva to Participate in Upcoming Investor Conferences
2026-05-06Press releasePDF Version
2026-05-06Press releaseInnoviva Reports First Quarter 2026 Financial Results; Highlights Recent Company Progress
2026-02-25Press releasePDF Version
2026-02-25Press releaseInnoviva Reports Fourth Quarter and Full Year 2025 Financial Results; Highlights Recent Company Progress
2026-02-19Press releasePDF Version
2026-02-19Press releaseInnoviva to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Press releaseInnoviva Reports Third Quarter 2025 Financial Results; Highlights Recent Company Progress
Press releaseInnoviva Reports Second Quarter 2025 Financial Results; Highlights Recent Company Progress
Press releaseInnoviva Reports First Quarter 2025 Financial Results; Highlights Recent Company Progress

INVA overview · INVA earnings · INVA financials · INVA KPIs · INVA documents · INVA ownership · INVA peers

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.